International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

S. Giralt; E.A. Stadtmauer; H.M. Lokhorst; the IMWG on behalf of

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

Translated title of the contribution: International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

S. Giralt, E.A. Stadtmauer, H.M. Lokhorst, the IMWG on behalf of

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).
Original language	Undefined/Unknown
Pages (from-to)	1904-1912
Number of pages	9
Journal	Leukemia
Volume	23
Issue number	10
Publication status	Published - 2009

Cite this

@article{eebd9367d7d24e1489b63b2f25f28ecd,

title = "International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).",

author = "S. Giralt and E.A. Stadtmauer and H.M. Lokhorst and {on behalf of}, {the IMWG}",

year = "2009",

language = "Undefined/Unknown",

volume = "23",

pages = "1904--1912",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "10",

}

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100). / Giralt, S.; Stadtmauer, E.A.; Lokhorst, H.M. et al.
In: Leukemia, Vol. 23, No. 10, 2009, p. 1904-1912.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

AU - Giralt, S.

AU - Stadtmauer, E.A.

AU - Lokhorst, H.M.

AU - on behalf of, the IMWG

PY - 2009

Y1 - 2009

M3 - Article

SN - 0887-6924

VL - 23

SP - 1904

EP - 1912

JO - Leukemia

JF - Leukemia

IS - 10

ER -